SCHEMBL30597527

SCHEMBL30597527

Cc1cc(C)c2nc(NC(=O)C3CCN(C(=O)OC(C)(C)C)CC3)sc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ NFKB1 P19838 1/20 0.54
▸ NFKB2 Q00653 1/20 0.54
▸ RELA Q04206 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ LCK P06239 1/20 0.53
▸ PTPN2 P17706 1/20 0.52
▸ PTPN1 P18031 1/20 0.52
▸ PTPN6 P29350 1/20 0.52
▸ EPHX2 P34913 2/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ RAB9A P51151 5/20 0.51
▸ KMT2A Q03164 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ LMNA P02545 2/20 0.48
▸ MAPT P10636 4/20 0.48
▸ HPGD P15428 1/20 0.47
▸ RORC P51449 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30597529 0.85 KMT2A (0.69) NPC1LCKPTPN2PTPN1PTPN6
SCHEMBL31419700 0.80 RAB9A (0.52) NPC1ALDH1A1NFKB1NFKB2RELA
SCHEMBL24071450 0.79 NPC1 (0.65) NPC1ALDH1A1SMN1; SMN2PTPN2PTPN1
SCHEMBL30597536 0.79 NPC1 (0.64) NPC1ALDH1A1NFKB1NFKB2RELA
SCHEMBL4396712 0.78 MAOA (0.64) NPC1ALDH1A1SMN1; SMN2LCKPTPN2
SCHEMBL5578506 0.76 PTPN2 (0.56) NPC1PTPN2PTPN1PTPN6EPHX2
SCHEMBL30597528 0.76 MAPT (0.73) ALDH1A1SMN1; SMN2L3MBTL1KMT2AMEN1
SCHEMBL30597505 0.76 MAPT (0.55) NPC1ALDH1A1NFKB1NFKB2RELA
SCHEMBL31420264 0.75 KMT2A (0.49) NPC1ALDH1A1SMN1; SMN2PTPN2PTPN1
SCHEMBL30597514 0.75 MAPT (0.64) ALDH1A1SMN1; SMN2EPHX2L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250250265-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF NACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D VANDERBILT UNIVERSITY 2025-08-07 — — US disclosed
WO-2023201014-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF N-ACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D VANDERBILT UNIVERSITY (US) 2023-10-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250265-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF NACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D PLD1, PLD2, NAPEPLD NPC1 1992/4885ALDH1A1 2820/4885NFKB1 2832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback